Stay
current with links to updates regarding BDI, our manufacturing trade
partners and industry events.
| |
|
Biotech Distributor BDI Pharma Unveils Online Ordering Portal |
| Columbia, SC – (Marketwire – August 17, 2010) - BDI Pharma, Inc. (BDI), the nation’s fastest growing national distributor of biotech therapies, announced the successful launch of its proprietary on-line ordering system. The system, initially rolled out earlier this month, provides BDI’s customers with the ability to place specialty pharmaceutical purchases on-line via the internet through a secure, facility-individualized ordering portal. Read
More |
| |
| |
|
Sales Revenue Exceeds Projections, BDI Pharma Demonstrates Continued Growth |
| Columbia, SC – (Marketwire – July 15, 2010) - BDI Pharma, Inc. (BDI), the nation’s fastest growing
national distributor of biotech therapies, announced that, in spite of the uncertainty of the nation’s current
economic climate, Sales Revenues continued to rise during the first two (2) fiscal quarters of 2010. This
expansion of business represented an increase of fifteen percent (15%) above that for the same period in
2009 and exceeded the company’s forecasted growth for the first six (6) months of the year. The
Specialty Biopharmaceutical class of products, primarily in the clinical areas of Oncology and Infectious
Disease, served as the primary driver for Sales Revenue during this period. Also notable were gains
within the Protein Biotherapeutics class, specific to the Hemophilia and Hyper-Immune product lines.
Read More |
| |
| |
|
Biotech Distributor BDI Pharma, Inc. Announces Record
Revenue Pace |
| Columbia, SC - (Marketwire
- April 14, 2010) - BDI Pharma, Inc. (BDI), the fastest growing
national distributor of biotech therapies, announced that sales for
the first quarter of 2010 represented an increase of more that
nineteen percent (19%) in comparison to the same time period in
2009.
Read More |
| |
|
Biotech Distributor BDI Pharma Celebrates 15th Anniversary in Conjunction with Successful Rebranding |
| Columbia, SC – (Marketwire – March 10, 2010) ‐ BDI Pharma, Inc. (BDI), the fastest growing national
distributor of biotech therapies, recognized two distinct milestones during the first quarter of 2010 – 15
years in business and the first anniversary of the organization’s re‐branding. BDI was founded on
January 27, 1995 as Blood Diagnostics, Inc. focusing primarily upon products that comprise the plasma
derivative and recombinant pharmaceutical market. In the latter half of 2007, the process of
significantly expanding the company's portfolio began.
Read More |
| |
|
Biotech Distributor BDI Pharma to Continue Accepting Flu Pre Books as New H1N1
Recommendation for Seasonal Vaccine Emerges |
| Columbia, SC – (Marketwire – March 4, 2010) ‐ BDI Pharma, Inc. (BDI), the fastest growing national
distributor of biotech therapies, will continue accepting pre book orders for the 2010 – 2011 flu
season, as recent recommendations provided by the FDA’s Vaccines and Related Biological Products
Advisory Committee suggest that manufacturers include the H1N1 strain in the upcoming seasonal flu
vaccine. Due to these recommendations, BDI anticipates an uptake in pre book orders.
Read More. |
| |
|
Biotherapeutics Distributor BDI Pharma, Inc. Launches Online
Ordering Site for Vaccines
|
Columbia, SC, December 16, 2009 – BDI Pharma, Inc. (BDI), the fastest growing national distributor of biotech therapies, announced today the introduction of SecuriVAXSM (www.securivax.com), an online supply solution providing the healthcare community a one-stop source for a wide variety of vaccines. As a result of its representation of multiple brands and indications, SecuriVAXSM allows customers the convenience of purchasing their vaccines in a single, easy-to-use location.
Read More |
| |
| BDI Pharma, Inc.’s Specialty Biotherapeutics Sales Outpace Expectations |
| Columbia, SC – (Marketwire – October 21, 2009) - BDI Pharma, Inc. (BDI), the fastest growing national distributor of biotech therapies, announced that revenue for the third quarter of 2009 continued to sustain the momentum experienced during the first two fiscal quarters of this year. A primary driver of third quarter revenue was the exceptional success of the company’s expanded portfolio of specialty biotherapeutics.
Read More |
|
| |
| Inaugural Season a
Success for BDI Pharma's SecuriFLU |
| Columbia, SC – (Marketwire – September 28, 2009) - BDI Pharma, Inc. (BDI), the fastest growing
national wholesale distributor of biotech therapies, announced today the success of its proprietary supply
program SecuriFLU. The program provides ordering solutions for customers who require quick, easy
access to online ordering for flu vaccine. Customers may access brands from multiple manufacturers
offering a full range of age indications. The site is designed to reduce the amount of time spent placing
orders and provide a user-controlled ordering process.
Read More |
|
| |
| Biotherapeutics Distributor BDI Pharma,
Inc.. Offers New Online Product Catalog |
| Columbia, SC - (Marketwire - July 20, 2009)
- BDI Pharma, Inc. (BDI), the nation’s fastest growing
distributor of specialty biotherapeutics, announced on July 1st the addition of an online product catalog,
available for download on the company’s corporate website.
Read More |
|
| |
| BDI Pharma, Inc. Surpasses XYNTHA Distribution Projections |
| Columbia, SC, May 20, 2009 - BDI Pharma, Inc. (BDI), the preeminent national wholesaler of specialty biopharmaceutical products, announced today that its Q1 distribution of Wyeth Pharmaceuticals' XYNTHA Antihemophilic Factor (Recombinant) - the manufacturer's new Plasma-Free and Albumin-Free recombinant factor VIII product - surpassed the company's projected forecast for that time period.
Read More |
|
| |
| Biotherapeutics Distributor BDI Pharma, Inc. Unveils Online Ordering Site for Flu Vaccine |
| Columbia, SC, May 8, 2009 – BDI Pharma, Inc. (BDI) the nation’s preeminent distributor of specialty biopharmaceuticals announced today the unveiling of SecuriFLU (www.securiflu.com), a new online supply solution where customers may pre-book orders for the upcoming flu season, as well as place orders for this year’s current strain.
Read More
|
|
| |
| BDI Pharma, Inc. to provide Lundbeck Inc.’s ATryn – the first recombinant antithrombin approved in the U.S. |
| Columbia, SC, May 6, 2009 – BDI Pharma, Inc. (BDI) announced today that it is the first specialty
biopharmaceutical distributor to be recognized as an official authorized distributor for ATryn® (Antithrombin
[Recombinant]). “We recognize the channel for this unique product’s distribution is to be limited and are very
pleased to be the initial distributor of ATryn in the U.S.,” said William Shirey, Executive Vice President of BDI.
Read More |
|
| |
|
Biotherapeutics Distributor
BDI Pharma, Inc. Unveils Rewards Program for Generic Oncology
Purchases
|
|
Columbia, SC, April 29, 2009 – BDI Pharma, Inc. (BDI) the nation’s
preeminent distributor of specialty biopharmaceuticals announced
last week the unveiling of QORe, a unique rewards program for
oncology physician practices and clinics.
Read More |
|
| |
| Blood Diagnostics, Inc. Becomes BDI Pharma,
Inc. |
| Significant Growth Leads to New Name and Corporate Headquarters |
| Columbia, SC, February 2, 2009 --
Blood Diagnostics, Inc., a national leader in the distribution of
biopharmaceutical products, announced that effective February 1,
2009 the company will begin operations from its new corporate
headquarters under the corporation's new name -- BDI Pharma, Inc.
Read More |
|
| |
| BDI Posts Record Sales Revenue |
| COLUMBIA, SC, January 9, 2009 -- BDI, A
national leader in the distribution of biopharmaceutical products,
announced that final figures for fiscal year 2008 indicated an
increase in Sales Revenue.
Read More |
|
| BDI Announces the Release of a New
Spanish Language Translation of Its Award-Winning Children's Book
|
| COLUMBIA, SC, Nov 10, 2008 -- BDI
(Blood Diagnostics, Inc.) is releasing a Spanish language
translation of its award-winning children's book on Hemophilia. BDI
originally sponsored the book in 2006 and has continued to provide
the story free of charge to healthcare and treatment facilities
throughout the county.
Read More |
|
| BDI (Blood Diagnostics, Inc.) Announces Record
Q3 Revenue Growth |
| Columbia, South Carolina - The influenza season of
2007-2008 saw the highest incidence if flu in recent years for
Indian County, Pennsylvania. In preparation of the 2008-2009 season,
the Indiana County Community Emergency/Disaster Planning Committee
and the Health and Human Services Subcommittee of Indiana,
Pennsylvania are staging a drill during the month of October to test
their PODS (Points of Dispensing Sites) System.
Read More |
|
| Indiana County - Preparing to make a difference
this flu season |
| Columbia, South Carolina - The
influenza season of 2007-2008 saw the highest incidence if flu in
recent years for Indian County, Pennsylvania. In preparation of the
2008-2009 season, the Indiana County Community Emergency/Disaster
Planning Committee and the Health and Human Services Subcommittee of
Indiana, Pennsylvania are staging a drill during the month of
October to test their PODS (Points of Dispensing Sites) System.
Read More |
|
| BDI (Blood Diagnostics, Inc.) Announces
Continued Growth through Q2 |
| Irmo, South Carolina (July 18, 2008) BDI, a
national leader in the distribution of biopharmaceutical products,
announced that sales for the first two quarters of 2008 continued to
demonstrate an increase of more than twenty percent (20%) in
comparison to same time period in 2007. With a history of strong
third and fourth quarter sales.
Read More |
|
| Blood Diagnoatics, Inc. Awarded MedAssets
Supply Chain Systems' Platinum Vendor Designation |
| Irmo, South Carolina (May, 8, 2008) --- Blood
Diagnostics, Inc. (BDI) today announced it recently earned MedAssets
Supply Chain Systems’ Platinum Vendor status. The platinum level is
the highest vendor designation awarded by MedAssets Supply Chain
Systems, a MedAssets company (NASDAQ: MDAS). Blood Diagnostics, Inc.
was awarded the Platinum Vendor designation at the MedAssets
Healthcare Business Summit in Las Vegas in March 2008, attended by
more than 3,000 healthcare professionals.
Read More |
|
| Blood Diagnostics, Inc. (BDI) Announces First
Quarter Growth |
| Irmo, South Carolina, April 28, 2008 - Blood
Diagnostics, Inc. (BDI), a national leader in the distribution of
biopharmaceutical products, announced that sales for the first
quarter of 2008.
Read More
|
|
| Blood Diagnostics, Inc. (BDI) Breaks Ground on
New Corporate Headquarters |
| Irmo, South Carolina - April 2, 2008 - Blood
Diagnostics, Inc. (BDI), a national leader in the distribution of
biopharmaceutical products, broke ground on its new corporate
headquarters.
Read More |
|
| Blood Diagnostics Announces Agreement with
Apotex to Distribute HepaGam B |
| Irmo, SC - Blood Diagnostics, Inc. (BDI),
one of the leading distributors of recombinant and plasma-derived
pharmaceutical products, today announced immediate availability of
HepaGam B, the first intravenous hepatitis B immune globulin
approved by the FDA.
Read More |
|
| |
| |
| |